Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126992631 | 12699263 | 1 | I | 20150923 | 20160830 | 20160830 | EXP | CA-CONCORDIA PHARMACEUTICALS INC.-CO-PL-CA-2016-444 | CONCORDIA | 43.00 | YR | F | Y | 0.00000 | 20160829 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126992631 | 12699263 | 1 | PS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | 0 | 400 | MG | QD | ||||||||
| 126992631 | 12699263 | 2 | SS | ARAVA | LEFLUNOMIDE | 1 | 0 | ||||||||||||
| 126992631 | 12699263 | 3 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 0 | |||||||||||
| 126992631 | 12699263 | 4 | SS | METHOTREXATE. | METHOTREXATE | 1 | Oral | 0 | 25 | MG | |||||||||
| 126992631 | 12699263 | 5 | SS | CORTISONE | CORTISONEHYDROCORTISONE | 1 | Oral | 0 | |||||||||||
| 126992631 | 12699263 | 6 | SS | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 126992631 | 12699263 | 7 | SS | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 126992631 | 12699263 | 8 | SS | SULFATHALIDINE | PHTHALYLSULFATHIAZOLE | 1 | 0 | ||||||||||||
| 126992631 | 12699263 | 9 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 0 | 1 | G | BID | ||||||||
| 126992631 | 12699263 | 10 | SS | REMICADE | INFLIXIMAB | 1 | 0 | ||||||||||||
| 126992631 | 12699263 | 11 | SS | ACTEMRA | TOCILIZUMAB | 1 | 0 | ||||||||||||
| 126992631 | 12699263 | 12 | SS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 126992631 | 12699263 | 13 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 0 | |||||||||||
| 126992631 | 12699263 | 14 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 0 | |||||||||||
| 126992631 | 12699263 | 15 | SS | RITUXAN | RITUXIMAB | 1 | 0 | ||||||||||||
| 126992631 | 12699263 | 16 | SS | SIMPONI | GOLIMUMAB | 1 | Subcutaneous | 0 | |||||||||||
| 126992631 | 12699263 | 17 | SS | REACTINE | CETIRIZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126992631 | 12699263 | 18 | SS | FOSAMAX | ALENDRONATE SODIUM | 1 | 0 | ||||||||||||
| 126992631 | 12699263 | 19 | C | XELJANZ | TOFACITINIB CITRATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126992631 | 12699263 | 1 | Product used for unknown indication |
| 126992631 | 12699263 | 3 | Rheumatoid arthritis |
| 126992631 | 12699263 | 4 | Rheumatoid arthritis |
| 126992631 | 12699263 | 5 | Rheumatoid arthritis |
| 126992631 | 12699263 | 6 | Rheumatoid arthritis |
| 126992631 | 12699263 | 7 | Rheumatoid arthritis |
| 126992631 | 12699263 | 9 | Rheumatoid arthritis |
| 126992631 | 12699263 | 10 | Rheumatoid arthritis |
| 126992631 | 12699263 | 11 | Rheumatoid arthritis |
| 126992631 | 12699263 | 12 | Rheumatoid arthritis |
| 126992631 | 12699263 | 13 | Rheumatoid arthritis |
| 126992631 | 12699263 | 14 | Rheumatoid arthritis |
| 126992631 | 12699263 | 15 | Rheumatoid arthritis |
| 126992631 | 12699263 | 16 | Rheumatoid arthritis |
| 126992631 | 12699263 | 17 | Rheumatoid arthritis |
| 126992631 | 12699263 | 18 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126992631 | 12699263 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126992631 | 12699263 | Abdominal discomfort | |
| 126992631 | 12699263 | Alopecia | |
| 126992631 | 12699263 | Glossodynia | |
| 126992631 | 12699263 | Pain | |
| 126992631 | 12699263 | Pemphigus | |
| 126992631 | 12699263 | Systemic lupus erythematosus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126992631 | 12699263 | 1 | 2006 | 0 | ||
| 126992631 | 12699263 | 4 | 2006 | 0 | ||
| 126992631 | 12699263 | 9 | 2006 | 2007 | 0 | |
| 126992631 | 12699263 | 12 | 20100510 | 201103 | 0 | |
| 126992631 | 12699263 | 15 | 2009 | 2010 | 0 |